NCT04253600

Brief Summary

For most children, language acquisition might appear like an effortless phenomenon, mostly arising from informal daily interaction with their surrounding people. Despite an adequate learning environment however, some children encounter major difficulties in learning their native tongue and develop a Developmental Language Disorder (DLD). Although the existence of a multi-factorial etiology has seemed to reach an agreement, presumably combining genetic and environmental factors to some kind of neural disruption, the underlying mechanisms leading to DLD are, to date, poorly understood. Many studies have attempted to identify risk factors and early predictors associated with the future development of a language impairment. However, despite the constant efforts to identify early markers able to differentiate between transient and persistent language difficulties, early detection of children who will be developing a DLD remains highly difficult, partially due to the lack of direct and ecological measures of early language and communication development. In addition research on the causal neural correlates of DLD is in its infancy, and often compromised by small sample sizes or analyses methods that lack anatomical specificity to determine the neural correlates of language impairment. Hence, In order to improve early detection and, therefore, language intervention, this longitudinal research project aims at investigating the early predictive factors as well as the neurocognitive basis of DLD by means of an integrative, multi-dimensional, and multi-methodological approach. To substantially gain insight, this research ideally integrates risk factors at multiple different levels, including the cognitive, neurobiological, parental and environmental level. From a methodological perspective, we will combine direct and indirect behavioral methods with neuroimaging methods in order to propose an early predictive model of language development.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2020

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

February 5, 2020

Status Verified

January 1, 2020

Enrollment Period

2.3 years

First QC Date

January 21, 2020

Last Update Submit

January 30, 2020

Conditions

Keywords

Developmental Language DisordersPredictive factorsNeural correlatesNeurocognitive basisLanguage developmentNatural-sleep MRI protocol

Outcome Measures

Primary Outcomes (6)

  • Environmental characteristics

    Online questionnaires to be completed by parents and evaluating environmental characteristics of the child.

    From 6 months to 48 months of age

  • Parental characteristics

    Online questionnaires to be completed by parents and evaluating parental characteristics of the child.

    From 6 months to 48 months of age

  • Children's behavioral characteristics (indirect measure)

    Online questionnaires to be completed by parents, which aims at evaluating children's development, and in particular, their language development.

    From 6 months to 48 months of age

  • Cognitive and behavioral characteristics (direct measure) as assessed by standardized batteries of tests

    Individual cognitive and behavioral assessment evaluating several developmental aspects including language, psychomotor, behavioral and cognitive development, as well as executive and socio-emotional functioning (e.g., EVALObb, EVALO2-6, WPPSI-IV). We will use batteries of neuropsychological standardized evaluation appropriate for the child's age.

    From 1 year to 4 years of age

  • Evaluation of children's language development and environment using the Language ENvironment Analysis digital language processor recording device (LENA)

    Automated analysis of language development and environment using the LENA device. An automatic analysis of the recordings, performed by the LENA pro software algorithms, will provide amongst others, a direct and natural measure of the child's number of vocalizations, adult word counts, conversational turns, duration of exposure to electronic media versus to meaningful language.

    From 1 year to 4 years of age

  • Magnetic Resonance Imagery analyses

    Evaluation of neural correlates of DLD using structural (and functional) images. Children aged from 6 months to 12(-18) months will be scanned only once.

    6-12 months old

Secondary Outcomes (1)

  • Risk profiles analysis based on risk screening online questionnaire

    0-18 months old (at screening)

Study Arms (1)

MRI Acquisition

OTHER

This does not refer to any group intervention. At-risk and control children will take part in a natural-sleep MRI protocol.

Behavioral: Risk profile screening questionnaireProcedure: Investigation of the neural correlates of DLD using Magnetic Resonance Imagery (MRI)Behavioral: Online investigation of predictive factors associated with DLD and LANCOM app developmentBehavioral: Individual behavioral and cognitive assessmentBehavioral: Automated analysis of language development and environment

Interventions

Families will be asked to complete a LimeSurvey questionnaire that aims at evaluating general risk profiles associated with DLD (e.g., no elevated risk, behavioral risk, environmental risk, familial risk), as well as our exclusion criteria (e.g., hearing deficit).

MRI Acquisition

MRI data acquisition will take place during natural sleep in infants aged from 6 to 12 months. First, families will have to complete a security questionnaire to make sure that neither the children nor the accompanying parent have any known contraindication preventing the MRI session and that none of them is wearing any ferro-magnetic elements. Then, families will be welcomed in a calm and child-friendly environment where we will propose them some preparatory games known to facilitate sleep in children. MRI protocol will comprise structural and functional images and won't exceed 30 minutes.

MRI Acquisition

Parents will be asked to complete a series of online questionnaires every six months. Questionnaires will be created on LimeSurvey and will include different questionnaires, scales, and observations that aim at evaluating children's development, and especially language development, as well as parental and environmental characteristics.

MRI Acquisition

Individual cognitive and behavioral assessment will be scheduled once a year, around the child's birth date, and will comprise an extensive battery of standardized evaluation appropriate for the child's age. This individual evaluation will focus on several developmental aspects including language, psychomotor, behavioral and cognitive development, as well as executive and socio-emotional functioning, depending on the age of the children. Evaluations will be adapted to each child's specific profile, while respecting the following administration rules: (1) we will prioritize language development testing, (2) testing sessions will be adapted to each child's pace and possibilities, (3) if a child does not want to take part in the assessment, feels tired, or does not seem to be comfortable with the investigator, tests won't be administered.

MRI Acquisition

Following the individual assessment, families will be asked to record their child's language environment over a 2-days' timeframe using the LENA® device, a "small wearable device allowing for large-scale all-day audio recording and automated vocal analyses of speech segments". An automatic analysis of the recordings, performed by the LENA pro software algorithms, will provide amongst others, a direct and natural measure of the child's number of vocalizations, adult word counts, conversational turns, duration of exposure to electronic media versus to meaningful language. Data acquisition will take place once a year following our sample selection, with a required recording time per day ranging from 12 to 16 hours.

MRI Acquisition

Eligibility Criteria

AgeUp to 18 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Having a child, preferably aged from 0 to 12 months, and a maximum of 18 months at the time of recruitment
  • Having French as (one of) mother tongue(s)

You may not qualify if:

  • Severe sensory deprivation resulting in hearing and/or visual impairment (i.e., deafness, blindness) detected at birth
  • Chromosomal abnormalities (e.g., Down syndrome, Turner syndrome, Williams syndrome)
  • Phenylketonuria
  • Cleft lips or palates

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Institut de recherche en sciences psychologiques (IPSY, UCLouvain)

Louvain-la-Neuve, 1348, Belgium

Location

Institute of NeuroScience (IoNS, UCLouvain)

Woluwe-Saint-Lambert, 1200, Belgium

Location

MeSH Terms

Conditions

Language Development Disorders

Interventions

Dihydrolipoamide DehydrogenaseEnvironment

Condition Hierarchy (Ancestors)

Language DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Glycine Decarboxylase ComplexMultienzyme ComplexesMultiprotein ComplexesMacromolecular SubstancesKetoglutarate Dehydrogenase ComplexPyruvate Dehydrogenase ComplexEnzymesEnzymes and CoenzymesKetone OxidoreductasesOxidoreductases Acting on Aldehyde or Oxo Group DonorsOxidoreductasesOxidoreductases Acting on Sulfur Group DonorsFlavoproteinsProteinsAmino Acids, Peptides, and ProteinsEcological and Environmental PhenomenaBiological PhenomenaEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2020

First Posted

February 5, 2020

Study Start

April 1, 2020

Primary Completion

August 1, 2022

Study Completion

August 31, 2024

Last Updated

February 5, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will share

As part of the evaluation of neural correlates, participants have to indicate in the inform consent form, whether they allow the research team to share their data with other researchers or not. Only anonymized MRI data are susceptible to be shared with other researchers if families explicitly mentioned it on inform consent.

Time Frame
Not specified at this time
Access Criteria
Only for people affiliated to the research institute or after signing a data use agreement.

Locations